Transforming M-protein diagnostics with mass spectrometry using the EXENT® System
Join Dr. Katie Horton, medical science liaison specialist – EXENT and Dr. Mark Perkins, senior manager, portfolio lifecycle – EXENT, The Binding Site, as they discuss the development and performance of the EXENT® System, a clinical mass spectrometry solution for monoclonal gammopathy assessment.
The EXENT System is an automated solution that enables M-protein identification and measurement in serum with enhanced sensitivity beyond conventional methods.
The system combines the EXENT Analyzer with the EXENT GAM Assay to provide a fully automated solution to isotype, quantify and track monoclonal proteins throughout the patient journey.
Key learning objectives
- Understand the role of mass spectrometry (MS) in monoclonal protein testing
- Explore the analytical performance of the EXENT System using MALDI-ToF MS technology
- Understand the potential clinical impact of mass spectrometry for patients with monoclonal gammopathies
Who should attend?
Laboratory professionals, hematologists, and primary care professionals who would like to learn more about the latest innovation for monoclonal gammopathy assessment.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
Dr. Mark Perkins has over 20 years of experience in the life science and diagnostic industry. He led the team responsible for the design and development of the EXENT solution and currently manages the team responsible for clinical and education evidence generation for the EXENT System.
Dr. Katie Horton has over five years’ experience working in a UK National Health Service (NHS) diagnostic clinic. She now works as a medical science liaison specialist using her mass spectrometry and clinical diagnostics expertise to help drive forward the clinical evidence generation and educational initiatives for the EXENT System.
Moderator
